RHIANNON FAHEY: Open Payments
NPI 1376935692 · TRINITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,165 in 186 payments from 43 companies in 2025. Trend: 2023 $1,619 · 2024 $1,632 · 2025 $4,165
Food & beverage: $4,145Education: $20
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $617 |
| Merck Sharp & Dohme LLC | 12 | $295 |
| Daiichi Sankyo Inc. | 10 | $219 |
| Novartis Pharmaceuticals Corporation | 18 | $207 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $187 |
| Astellas Pharma US Inc | 9 | $182 |
| GlaxoSmithKline, LLC. | 10 | $180 |
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| Regeneron Healthcare Solutions, Inc. | 6 | $173 |
| GENZYME CORPORATION | 7 | $163 |
Products named: RYBREVANT, KEYTRUDA, Enhertu, Nubeqa, LIBTAYO, RYTELO, FRUZAQLA, OJJAARA.
Industry payments across FL — which companies pay providers there.
